SATRIX COLLECTIVE Lists 400K STXRAF Securities, Boosting Investment Opportunities

  • SATRIX COLLECTIVE INVESTMENT SCHEME lists additional 400,000 securities for its SATRIX RAFI 40 portfolio.
  • STXRAF securities made available for trading at an issue price of approximately R23.19 per security.
  • Total number of STXRAF securities in circulation reaches 58,077,270, enhancing investment opportunities and liquidity.
Satrix

SATRIX COLLECTIVE INVESTMENT SCHEME announced today the listing of an additional 400,000 securities for its popular SATRIX RAFI 40 portfolio. The new securities, identified by the JSE code STXRAF, became available for trading as of the commencement of business today. This strategic move aims to expand investment opportunities for individuals seeking exposure to the SATRIX RAFI 40 index.

As a registered portfolio in terms of the Collective Investment Schemes Control Act, 45 of 2002, SATRIX Collective Investment Scheme has been known for providing investors with a wide range of investment options tailored to meet their diverse needs. The SATRIX RAFI 40 portfolio, in particular, has gained popularity for its focus on fundamentally weighted investments, granting investors access to a diversified basket of 40 South African equities.

The recent listing of an additional 400,000 STXRAF securities was made available at an issue price of approximately R23.19 per security. With this new listing, the total number of STXRAF securities in circulation will amount to an impressive 58,077,270. The expansion in the availability of these securities seeks to satisfy the growing demand from investors keen on exploring the potential of the SATRIX RAFI 40 portfolio.

Investors who have opted for the SATRIX RAFI 40 portfolio have been able to benefit from its strong historical performance and its ability to capture favorable opportunities within the South African equity market. With the introduction of an increased number of securities, SATRIX aims to accommodate a wider range of investors, thereby enhancing liquidity and overall market participation.

To oversee the listing process and ensure a seamless trading experience, SATRIX COLLECTIVE INVESTMENT SCHEME has partnered with Vunani Sponsors, a respected JSE Sponsor. This collaboration demonstrates the commitment of both organizations to upholding the highest standards of transparency and regulatory compliance.

The listing of additional STXRAF securities presents an exciting prospect for investors seeking exposure to the SATRIX RAFI 40 portfolio, renowned for its strong performance track record and its emphasis on fundamental weightings. As the investment landscape continues to evolve, SATRIX remains dedicated to offering innovative investment solutions that align with the evolving needs of investors.

Visited 1 times, 1 visit(s) today
Do you have a news tip for Rateweb reporters? Please email us at

Sponsored

Start trading with a free $30 bonus

Trade stocks, forex, commodities, metals and CFDs on stock indices with an internationally licensed and regulated broker. For all clients who open their first real account, XM offers a $30 trading bonus without any initial deposit needed. Learn more about how you can trade over 1000 instruments on the XM MT4 and MT5 platforms from your PC and Mac, or from a variety of mobile devices.

Related

Rateweb

South Africa’s primary source of financial tools and information

Contact Us

admin@rateweb.co.za

Disclaimer

Rateweb strives to keep its information accurate and up to date. This information may be different than what you see when you visit a financial institution, service provider or specific product’s site. All financial products, shopping products and services are presented without warranty. When evaluating offers, please review the financial institution’s Terms and Conditions.

Rateweb is not a financial service provider and should in no way be seen as one. In compiling the articles for our website due caution was exercised in an attempt to gather information from reliable and accurate sources. The articles are of a general nature and do not purport to offer specialised and or personalised financial or investment advice. Neither the author, nor the publisher, will accept any responsibility for losses, omissions, errors, fortunes or misfortunes that may be suffered by any person that acts or refrains from acting as a result of these articles.